Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis.

The primary aim of this study was to analyze human colon cancer and normal adjacent tissue using (1)H HR MAS MR spectroscopy and chemometric analyses, evaluating possible biomarkers for colon cancer. The secondary aim was to investigate metabolic profiles of tissue samples (n = 63, 31 patients) with microsatellite instability (MSI-H) compared to microsatellite stable (MSS) colon tissue. Our hypothesis was that this method may provide an alternative to MSI genotyping. Cancer samples were clearly separated from normal adjacent mucosa by 100% accuracy. Several metabolites such as lactate, taurine, glycine, myo-inositol, scyllo-inositol, phosphocholine (PC), glycerophosphocholine (GPC), creatine, and glucose were identified as potential biomarkers for cancer detection. Adenomas (n = 4) were also separated from cancer and normal samples mainly based on higher GPC and PC levels. Interestingly, metabolic differences in normal colon mucosa between MSI-H and MSS patients were observed. MSI status was validated with 80% accuracy with a sensitivity and specificity of 79% and 82%, respectively, including both cancer and normal samples The metabolic differences between MSI-H and MSS may be very interesting in the early detection of cancer development and of high clinical importance in the work of improving diagnosis and characterization of colon cancer.

[1]  T. Bathen,et al.  MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status , 2007, Breast Cancer Research and Treatment.

[2]  B. Uzzan,et al.  Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis. , 2009, European journal of cancer.

[3]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[4]  T. Schroeder,et al.  Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. , 2004, Current medicinal chemistry.

[5]  F. Howe,et al.  Taurine: a potential marker of apoptosis in gliomas , 2009, British Journal of Cancer.

[6]  L. Vatten,et al.  Awareness of heredity in colorectal cancer patients is insufficient among clinicians: a Norwegian population‐based study , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[7]  Takuji Tanaka.  Colorectal carcinogenesis: Review of human and experimental animal studies , 2009, Journal of carcinogenesis.

[8]  Kentaro Yamashita,et al.  Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. , 2006, Cancer cell.

[9]  A. de la Chapelle,et al.  Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. , 2000, The American journal of pathology.

[10]  R. Houlston,et al.  Systematic review of microsatellite instability and colorectal cancer prognosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  M. Cocchi,et al.  Discrimination of healthy and neoplastic human colon tissues by ex vivo HR-MAS NMR spectroscopy and chemometric analyses. , 2009, Journal of proteome research.

[12]  Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study , 2010, British Journal of Cancer.

[13]  D. Leibfritz,et al.  Changes in organic solutes, volume, energy state, and metabolism associated with osmotic stress in a glial cell line: A multinuclear NMR study , 1995, Neurochemical Research.

[14]  Leo L. Cheng,et al.  Metabolomic Characterization of Human Rectal Adenocarcinoma with Intact Tissue Magnetic Resonance Spectroscopy , 2009, Diseases of the colon and rectum.

[15]  L. A. Stone,et al.  Computer Aided Design of Experiments , 1969 .

[16]  R. Lothe,et al.  Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers , 2008, Molecular Cancer.

[17]  M. E. Clark,et al.  Living with water stress: evolution of osmolyte systems. , 1982, Science.

[18]  J. Kurhanewicz,et al.  Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR‐MAS spectroscopy of biopsy tissues , 2008, Magnetic resonance in medicine.

[19]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[20]  G. Watanabe,et al.  DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer , 2006, British Journal of Cancer.

[21]  中神 克尚.  Increased choline Kinase activity and elevated phosphocholine levels in human colon cancer , 2000 .

[22]  H. Körner,et al.  Microsatellite instability in colorectal cancer , 2006, The British journal of surgery.

[23]  B. Uzzan,et al.  Microsatellite instability: a predictive marker in metastatic colorectal cancer? , 2009, Targeted Oncology.

[24]  Elaine Holmes,et al.  Topographical variation in metabolic signatures of human gastrointestinal biopsies revealed by high-resolution magic-angle spinning 1H NMR spectroscopy. , 2007, Journal of proteome research.

[25]  T. Bathen,et al.  Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1 H magnetic resonance spectroscopy , 2008 .

[26]  Rachel Cavill,et al.  Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). , 2009, Journal of proteome research.

[27]  Jostein Halgunset,et al.  Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy , 2008, Molecular Cancer.

[28]  C. Arús,et al.  1H NMR spectroscopy of colon tumors and normal mucosal biopsies; elevated taurine levels and reduced polyethyleneglycol absorption in tumors may have diagnostic significance , 1993, NMR in biomedicine.

[29]  John T. Wei,et al.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.

[30]  T. Bathen,et al.  Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics. , 2010, Journal of proteome research.

[31]  Ellen Ackerstaff,et al.  Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. , 2006, Molecular pharmaceutics.

[32]  J. Nicholson,et al.  Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology. , 2010, Journal of proteome research.

[33]  S. Meiboom,et al.  Modified Spin‐Echo Method for Measuring Nuclear Relaxation Times , 1958 .

[34]  T. Bathen,et al.  Characterization of brain metastases using high‐resolution magic angle spinning MRS , 2008, NMR in biomedicine.

[35]  Daniel J Sargent,et al.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. , 2003, The New England journal of medicine.

[36]  Y. Hu,et al.  DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer , 2010, Oncogene.

[37]  A. Imperiale,et al.  Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1H magnetic resonance spectroscopy , 2009, Metabolomics.

[38]  O. Warburg.  On the origin of cancer cells. , 1956, Science.

[39]  A. Navarro,et al.  Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions. , 2008, European journal of cancer.